Tendencias en la hospitalización de complicaciones neurológicas de diabetes mellitus en el área de Palencia en el periodo 1993-2017

  1. Gonzalo Magdaleno Marcos 1
  2. José I. Martín Serradilla 2
  3. Jesús María de Andrés de Llano 3
  4. Irene Andrés Alberola 4
  5. Francisco Emilio Per Contreras 5
  6. María Eirín Feijoo 6
  7. Carmen Fernández Morado 7
  1. 1 Atención Familiar y Comunitaria (UDM de AFyC) de Vigo. Centro de Salud de Porriño. Servicio Gallego de Salud (SERGAS). Vigo. España
  2. 2 Unidad de Diagnóstico Rápido. Servicio de Medicina Interna. Complejo Asistencial Universitario de Palencia. Gerencia Regional de Salud de Castilla y León (SACYL). Palencia. España.
  3. 3 Unidad de Investigación. Complejo Asistencial Universitario de Palencia. Gerencia Regional de Salud de Castilla y León (SACYL). Palencia. España.
  4. 4 Atención Familiar y Comunitaria de Palencia. Complejo Asistencial Universitario de Palencia. Gerencia Regional de Salud de Castilla y León (SACYL). Palencia. España
  5. 5 Atención Familiar y Comunitaria (UDM de AFyC) de Vigo. Centro de Salud de Teis. Servicio Gallego de Salud (SERGAS). Vigo. España.
  6. 6 Atención Familiar y Comunitaria (UDM de AFyC) de Vigo. Centro de Salud de Sardoma. Servicio Gallego de Salud (SERGAS). Vigo. España.
  7. 7 Servicio de Medicina Interna A Coruña. Complejo Hospitalario Universitario de A Coruña. Servicio Gallego de Salud (SERGAS). A Coruña. España.
Mostra les afiliacions +
Revista:
Academic Journal of Health Sciences: Medicina Balear

ISSN: 2255-0560

Any de publicació: 2023

Volum: 38

Número: 2

Pàgines: 95-99

Tipus: Article

DOI: 10.3306/AJHS.2023.38.02.95 DIALNET GOOGLE SCHOLAR lock_openIbdigital editor

Resum

Introduction: Trends of hospital admissions in the health area of Palencia in the period 1993-2017 of patients with neurological complications (NC) of Diabetes Mellitus (DM) is analyzed, based on the information recorded in the Minimum Basic Data Set (MBDS). Methods: Cross-association study of hospital discharges from the Palencia University Assistance Complex between 1993-2017, based on the MBDS, with the diagnoses of DM and the subcategories of DM with neurological manifestations. General descriptive, bivariate, multivariate analysis and joinpoint regression analysis to check trend changes. Results: The MBDS consisted of 410218 records; 48225 (11.8%) included the codes 249.xx and 250.xx (CIE-9), and 969 (2%) had NC. Hospitalization of patients with DM grew annually by 9.4 between 1993-2008, with a breaking point in 2008, and decreased annually by -0.3 between 2008-2017. Hospitalization of patients with NC of DM grew by 3.4 annually between 1993- 2014, with a break point in 2014, and decreased annually by -23.9 between 2014-2017. Conclusions: The MBDS provides valuable information that can be extrapolated to that of the population as a whole. Joinpoint logistic regression models make it possible to quantify trends, check changes in them, plan resources to meet future health demands, and evaluate the effects of preventive activities. The publication between 2004 and 2008 of different clinical practice guidelines may explain the subsequent reduction in hospitalizations of diabetic patients. However, there is an underestimation in the NC of DM in the MBDS.

Referències bibliogràfiques

  • Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018 Apr;138:271-281. doi: 10.1016/j.diabres.2018.02.023
  • Carrera-Lasfuentes P, Abad JM, Aguilar-Palacio I, Rabanaque MJ. Comorbilidad como predictor de utilización de servicios sanitarios y mortalidad en pacientes con diabetes [Comorbidity as a predictor of health services utilization and mortality in patients with diabetes]. Gac Sanit. 2015 Jan-Feb;29(1):10-4. doi: 10.1016/j.gaceta.2014.07.008. Epub 2014 Sep 5. PMID: 25200482.
  • Zapatero-Gaviria A, Gómez-Huelgas R, Canora-Lebrato J, Ena-Muñoz J, Romero-Sánchez M, Mendez-Bailón M, et al. Analysis of hospitalizations by cardiovascular disease in the population with diabetes in Spain. Rev Clin Esp (Barc). 2019 Apr;219(3):124-129. English, Spanish. doi: 10.1016/j.rce.2018.09.012.
  • Lopez-de-Andres A, Carrasco-Garrido P, Esteban-Hernandez J, Gil-de- Miguel A, Jiménez-García R. Characteristics and hospitalization costs of patients with diabetes in Spain. Diabetes Res Clin Pract. 2010 Jul;89(1):e2-4. doi: 10.1016/j.diabres.2010.03.026. PMID: 20435367.
  • Deli G, Bosnyak E, Pusch G, Komoly S, Feher G. Diabetic neuropathies: diagnosis and management. Neuroendocrinology. 2013;98(4):267-80. doi: 10.1159/000358728. Epub 2014 Jan 22. PMID: 24458095.
  • Martin S, Schramm W, Schneider B, Neeser K, Weber C, Lodwig V, et al. Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4). Exp Clin Endocrinol Diabetes. 2007 Sep;115(8):495-501. doi: 10.1055/s-2007-981470.
  • Olm M, Kühnl A, Knipfer E, Salvermoser M, Eckstein HH, Zimmermann A. Operative Versorgung von Diabetikern mit vaskulären Komplikationen : Sekundärdatenanalyse der DRG-Statistik von 2005 bis 2014 in Deutschland [Operative treatment of diabetics with vascular complications : Secondary data analysis of diagnosis-related groups statistics from 2005 to 2014 in Germany]. Chirurg. 2018 Jul;89(7):545-551. doi: 10.1007/s00104-018-0628-z. PMID: 29589075.
  • López-Messa JB, Andrés-de Llano JM, López-Fernández L, García-Cruces J, García-Crespo J, Prieto González M. Evolución de las tasas de hospitalización y mortalidad hospitalaria por enfermedades cardiovasculares agudas en Castilla y León, 2001-2015 [Trends in Hospitalization and Mortality Rates Due to Acute Cardiovascular Disease in Castile and León, 2001 to 2015]. Rev Esp Cardiol. 2018 Feb;71(2):95-104. doi: 10.1016/j.rec.2017.04.033. Epub 2017 Jul 31. PMID: 28774633.
  • Thomas PK. Diabetic peripheral neuropathies: their cost to patient and society and the value of knowledge of risk factors for development of interventions. Eur Neurol. 1999;41 Suppl 1:35-43. doi: 10.1159/000052078. PMID: 10023127.
  • Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med. 2009 Dec 20;28(29):3670-82. doi: 10.1002/sim.3733. PMID: 19856324; PMCID: PMC2843083.
  • Cayuela L, Rodriguez S, Giráldez Gallego Á, Cayuela A. Regional Differences in Colorectal Cancer Mortality Trends, Spain (1980-2018). Rev Esp Enferm Dig. 2020 Dec 2. doi: 10.17235/reed.2020.7183/2020. Epub ahead of print. PMID: 33261500.
  • Cayuela A, Cayuela L, Ortega Belmonte MJ, Rodríguez-Domínguez S, Escudero-Martínez I, González A. ¿Ha dejado de disminuir la mortalidad por enfermedades cerebrovasculares en España? [Has stroke mortality stopped declining in Spain?] Neurologia. 2019 Nov 25:S0213-4853(19)30106-9. doi: 10.1016/j.nrl.2019.06.001. Epub ahead of print. PMID: 31780318.
  • American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2005 Jan;28 Suppl 1:S4-S36. PMID: 15618112.
  • American Diabetes Association. Standards of medical care in diabetes--2007. Diabetes Care. 2007 Jan;30 Suppl 1:S4-S41. doi: 10.2337/dc07-S004. PMID: 17192377.
  • American Diabetes Association. Standards of medical care in diabetes--2008. Diabetes Care. 2008 Jan;31 Suppl 1:S12-54. doi: 10.2337/dc08-S012. PMID: 18165335.
  • National Collaborating Centre for Chronic Conditions (UK). Type 1 Diabetes in Adults: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care. London: Royal College of Physicians (UK); 2004. PMID: 21938859.
  • National Collaborating Centre for Chronic Conditions (UK). Type 2 Diabetes: National Clinical Guideline for Management in Primary and Secondary Care (Update). London: Royal College of Physicians (UK); 2008. (NICE Clinical Guidelines, No. 66.) Available from: https://www.ncbi.nlm.nih. gov/books/NBK53885/
  • Ministerio de Sanidad y Consumo. Ministerio de Sanidad y Servicios Sociales. Guia de práctica clínica sobre Diabetes Mellitus tipo 2. Serv Cent Comun del Gob Vasco [Internet]. 2017;1–181. Available from: https:// portal.guiasalud.es/wp-content/uploads/2018/12/GPC_429_Diabetes_2_Osteba_compl.pdf
  • Vithian K, Hurel S. Microvascular complications: pathophysiology and management. Clin Med (Lond). 2010 Oct;10(5):505-9. doi: 10.7861/clinmedicine.10-5-505. PMID: 21117389; PMCID: PMC4952418.
  • American Diabetes Association. 10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018 Jan;41(Suppl 1):S105-S118. doi: 10.2337/dc18-S010. PMID: 29222381.
  • Librero J, Peiró S, Ordiñana R. Comorbilidad crónica y homogeneidad de los grupos de diagnósticos relacionados [Chronic comorbidity and homogeneity in diagnostic related groups]. Gac Sanit. 1999 Jul-Aug;13(4):292-302. Spanish. doi: 10.1016/s0213-9111(99)71371-3. PMID: 10490668.
  • Griffiths R, Hindle D. The effectiveness of AN-DRGs in classification of acute admitted patients with diabetes. Health Inf Manag. 1999 Jun-Aug;29(2):77-83. doi: 10.1177/183335839902900208. PMID: 10977181.
Fuente de los datos: Dialnet